FIELD: organic chemistry, medicine, pharmacy.
SUBSTANCE: invention relates to a novel compound of the general formula (I): 
wherein R means hydrogen atom (H), -OH, carbamoyl group; n = 1 or 2, or to its pharmaceutically acceptable salt. Compounds of the formula (I) are potential inhibitors of cellular adhesion mediated by integrins that allows its using as components of pharmaceutical composition used in treatment or prophylaxis of inflammatory, autoimmune or allergic state or rejection mediated by LFA-1.
EFFECT: valuable medicinal properties of compound and pharmaceutical composition.
19 cl, 2 sch, 3 dwg, 3 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| 2-AZA-BICYCLO[3,3,0]OCTANE DERIVATIVES | 2008 |
|
RU2478099C2 |
| AMIDES OF DIAZABICYCLOALKANES, SELECTIVE WITH RESPECT TO ACETYLCHOLINE SUBTYPE OF NICOTINE RECEPTORS AND PHARMACEUTIC COMPOSITION AND METHODS OF TREATMENT WITH THEIR APPLICATION | 2007 |
|
RU2448969C2 |
| AMIDES OF DIASABICYCLOALKANES, SELECTIVE WITH RESPECT TO ACETYLCHOLINE SUBTYPE OF NICOTINIC RECEPTORS | 2007 |
|
RU2517693C2 |
| 5-[(PIPERAZIN-1-YL)-3-OXO-PROPYL]-IMIDAZOLIDINE-2,4-DIONE DERIVATIVES AS ADAMTS INHIBITORS FOR TREATING OSTEOARTHRITIS | 2015 |
|
RU2693459C2 |
| AZASPIROALKANE DERIVATIVES METALLOPROTEASE INHIBITORS | 2004 |
|
RU2379303C2 |
| DERIVATIVES OF DIAZABICYCLIC ALKANES ELICITING NK-ANTAGONISTIC ACTIVITY | 2003 |
|
RU2310656C2 |
| CRYSTALLINE FORMS OF DIAZABICLOCTANE DERIVATIVE AND A METHOD OF THEIR PRODUCTION | 2014 |
|
RU2801220C2 |
| CRYSTALLINE FORMS OF DIAZABICYCLOOCTANE DERIVATIVE AND METHOD FOR PRODUCTION THEREOF | 2014 |
|
RU2695219C2 |
| PROCESS FOR PRODUCING DERIVATIVES OF PROSTACYCLINE OR THEIR SALTS | 0 |
|
SU1003754A3 |
| METHOD FOR PRODUCING DERIVATIVES OF CARBACYCLINES OR THEIR ADDITIVE-BASIC SALTS OF TRIS-(OXYMETHYL)-AMINOMETHAN | 0 |
|
SU1316555A3 |
